
1. bioorg med chem lett. 2011 apr 15;21(8):2450-5. doi: 10.1016/j.bmcl.2011.02.058. 
epub 2011 feb 23.

design synthesis pyridin-2-yloxymethylpiperidin-1-ylbutyl amide ccr5
antagonists potent inhibitors m-tropic (r5) hiv-1 replication.

skerlj r(1), bridger g, zhou y, bourque e, langille j, di fluri m, bogucki d,
yang w, li t, wang l, nan s, baird i, metz m, darkes m, labrecque j, lau g,
fricker s, huskens d, schols d.

author information: 
(1)genzyme corp., 153 second avenue, waltham, 02451, usa.
renato.skerlj@genzyme.com

a novel series ccr5 antagonists identified based redesign of
schering c. sar established based inhibition ccr5 (rantes) binding
and compounds exhibited potent inhibition r5 hiv-1 replication in
peripheral blood mononuclear cells.

copyright Â© 2011 elsevier ltd. rights reserved.

doi: 10.1016/j.bmcl.2011.02.058 
pmid: 21398122  [indexed medline]

